Brokerages Set Biogen Inc. NASDAQ:BIIB Target Price at

Biogen Inc., a renowned biotechnology company, has recently attracted the attention of Edgestream Partners L.P. The investment firm has increased its holdings in Biogen Inc., indicating a growing interest in the company's stock. This move by Edgestream Partners L.P. highlights the potential value and profitability of Biogen Inc. in the market. In related news, Royal London Asset Management Ltd. has decided to sell some of its shares in the company, possibly due to a change in investment strategy. However, this does not deter RA Capital Management L.P. from seeing the potential of Biogen Inc. They have recently purchased shares, demonstrating their confidence in the company's future growth. Biogen Inc. continues to be a subject of interest for brokerages, with many setting a target price for its stock. Investors who are considering Biogen Inc. may benefit from seeking professional advice from experts in Stocks Prognosis, who can provide valuable insights and forecasts on the movement of Biogen Inc.'s shares.